Yousun Chung

Yousun Chung

Auto-generated profile, based on publicly available information

Yousun Chung

Department of Laboratory Medicine Kangdong Sacred Heart Hospital Seoul Republic of Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2019 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
JYJohn Jeongseok Yang
John Jeongseok Yang
YCYousun Chung
Yousun Chung
HKHyungsuk Kim
Hyungsuk Kim
DKDae-Hyun Ko
Dae-Hyun Ko
SHSang-Hyun Hwang
Sang-Hyun Hwang
HOHeung-Bum Oh
Heung-Bum Oh
Objectives: We reanalyzed the data from proficiency testing (PT) to assess the effect of the geometric mean in the statistical analysis of immunohematologic data. Methods: Using the five most recent anti–blood group antibody titer participant summary results, the geometric mean (GM) ±2 × geometric standard deviation (GSD) was used as the comparative consensus criterion to mode ±2 titers. Results: Using the PT evaluation criterion of mode ±2 titers, the mean percentages of participants with acceptable results were 97.5% and 97.8% for anti-A and anti-D, respectively. When applying GM ±2 GSD, the mean percentages of acceptable results were 96.1% (anti-A) and 96.1% (anti-D). The percentages of responses included in each consensus criterion were lower using GM ±2 GSD, with a few exceptions. Conclusions: Geometric means are more robust and precise in visualizing the central tendency. This method can improve the statistical robustness of PT evaluations.

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
MKMi-Na Kim
Mi-Na Kim
JKJin Seok Kim
Jin Seok Kim
HPHyewon Park
Hyewon Park
YCYousun Chung
Yousun Chung
HKHyungsuk Kim
Hyungsuk Kim
HOHeung-Bum Oh
Heung-Bum Oh
Kim MS, et al. J Korean Med Sci. 2019 Sep;34(39):e258. https://doi.org/10.3346/jkms.2019.34.e258

30 June 2021 in Laboratory Medicine and Quality Assurance
Verified
Journal Article
Open access
PDF file
YCYousun Chung
Yousun Chung
JKJin Seok Kim
Jin Seok Kim
JYJohn Jeongseok Yang
John Jeongseok Yang
HKHyungsuk Kim
Hyungsuk Kim
SHSANG-HYUN HWANG
SANG-HYUN HWANG
DKDae-Hyun Ko
Dae-Hyun Ko
Yousun Chung, Jin Seok Kim, John Jeongseok Yang, Hyungsuk Kim, Sang-Hyun Hwang, Heung-Bum Oh, and Dae-Hyun Ko. Lab Med Qual Assur 2021;43:87-93. https://doi.org/10.15263/jlmqa.2021.43.2.87

1 January 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
YCYousun Chung
Yousun Chung
DKDae-Hyun Ko
Dae-Hyun Ko
JLJihyang Lim
Jihyang Lim
KKKyeong-Hee Kim
Kyeong-Hee Kim
HKHyungsuk Kim
Hyungsuk Kim
PHPh.D.
Ph.D.
Yousun Chung, M.D., Dae-Hyun Ko, M.D., Ph.D., Jihyang Lim, M.D., Ph.D., Kyeong-Hee Kim, M.D., Ph.D., and Hyungsuk Kim, M.D.. Ann Lab Med 2022;42:105-9. https://doi.org/10.3343/alm.2022.42.1.105

24 May 2022 in Korean Journal of Transplantation
Verified
Journal Article
Open access
PDF file
YCYousun Chung
Yousun Chung
DKDae-Hyun Ko
Dae-Hyun Ko
Yousun Chung, Dae-Hyun Ko. Korean J Transplant 2022;36:99-103. https://doi.org/10.4285/kjt.22.0011

10 September 2024 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
HKHan Joo Kim
Han Joo Kim
YCYousun Chung
Yousun Chung
HKHyungsuk Kim
Hyungsuk Kim
YKYoungmin Ko
Youngmin Ko
YKYoung Hoon Kim
Young Hoon Kim
DKDae-Hyun Ko
Dae-Hyun Ko
Objectives: This study aimed to evaluate whether a 2-week period of daily isoagglutinin titer testing after ABO-incompatible kidney transplantation (ABOi-KT) is sufficient to ensure successful engraftment and to advocate for an extension of the monitoring duration in specific situations. Methods: We reviewed patients from January 2022 to December 2023 at Asan Medical Center who underwent therapeutic plasma exchange (TPE) due to elevated ABO antibody titers and suspected acute antibody-mediated rejection (AMR) after ABOi-KT. Data collected included pre- and posttransplantation laboratory results, clinical and procedural information, imaging studies, and needle biopsy results of the renal graft. Results: We encountered 3 cases of acute AMR 2 weeks after transplantation. All cases exhibited simultaneous increases in anti-ABO antibody isoagglutinin titers, creatinine, and C-reactive protein levels. Clinical signs, including fever, suggested possible infection, and renal graft biopsy, confirmed AMR in all cases. Two cases underwent graftectomy, while the third recovered renal function after conservative treatment, including TPE. Conclusions: Our findings suggest that a 2-week monitoring period for isoagglutinin titers after ABOi-KT may not be sufficient to detect late AMR. Extending the monitoring duration and considering lifelong fresh-frozen plasma transfusion with graft-compatible blood types, along with periodic isoagglutinin titer testing in cases of suspected AMR, may improve long-term graft outcomes.